Persistent varicella zoster virus infection following mRNA COVID‐19 vaccination was associated with the presence of encoded spike protein in the lesion

Abstract Background Since the campaign of vaccination against COVID‐19 was started, a wide variety of cutaneous adverse effects after vaccination has been documented worldwide. Varicella zoster virus (VZV) reactivation was reportedly the most frequent cutaneous reaction in men after administration o...

Full description

Saved in:
Bibliographic Details
Main Authors: Mayuko Yamamoto (Author), Misaki Kase (Author), Hozumi Sano (Author), Reiko Kamijima (Author), Shigetoshi Sano (Author)
Format: Book
Published: Frontiers Media S.A., 2023-02-01T00:00:00Z.
Subjects:
Online Access:Connect to this object online.
Tags: Add Tag
No Tags, Be the first to tag this record!

MARC

LEADER 00000 am a22000003u 4500
001 doaj_883fc9ab78e04b82bd8ccbb99d9b7e66
042 |a dc 
100 1 0 |a Mayuko Yamamoto  |e author 
700 1 0 |a Misaki Kase  |e author 
700 1 0 |a Hozumi Sano  |e author 
700 1 0 |a Reiko Kamijima  |e author 
700 1 0 |a Shigetoshi Sano  |e author 
245 0 0 |a Persistent varicella zoster virus infection following mRNA COVID‐19 vaccination was associated with the presence of encoded spike protein in the lesion 
260 |b Frontiers Media S.A.,   |c 2023-02-01T00:00:00Z. 
500 |a 2574-4593 
500 |a 10.1002/cia2.12278 
520 |a Abstract Background Since the campaign of vaccination against COVID‐19 was started, a wide variety of cutaneous adverse effects after vaccination has been documented worldwide. Varicella zoster virus (VZV) reactivation was reportedly the most frequent cutaneous reaction in men after administration of mRNA COVID‐19 vaccines, especially BNT162b2. Aims A patient, who had persistent skin lesions after BNT162b2 vaccination for such a long duration over 3 months, was investigated for VZV virus and any involvement of vaccine‐derived spike protein. Materials & Methods Immunohistochemistry for detection of VZV virus and the spike protein encoded by mRNA COVID‐19 vaccine. PCR analysis for VZV virus. Results The diagnosis of VZV infection was made for these lesions using PCR analyses and immunohistochemistry. Strikingly, the vaccine‐encoded spike protein of the COVID‐19 virus was expressed in the vesicular keratinocytes and endothelial cells in the dermis. Discussion mRNA COVID‐19 vaccination might induce persistent VZV reactivation through perturbing the immune system, although it remained elusive whether the expressed spike protein played a pathogenic role. Conclusion We presented a case of persistent VZV infection following mRNA COVID‐19 vaccination and the presence of spike protein in the affected skin. Further vigilance of the vaccine side effect and investigation for the role of SP is warranted. 
546 |a EN 
690 |a mRNA COVID‐19 vaccine 
690 |a spike protein 
690 |a varicella zoster virus reactivation 
690 |a vasculitis 
690 |a Dermatology 
690 |a RL1-803 
690 |a Immunologic diseases. Allergy 
690 |a RC581-607 
655 7 |a article  |2 local 
786 0 |n Journal of Cutaneous Immunology and Allergy, Vol 6, Iss 1, Pp 18-23 (2023) 
787 0 |n https://doi.org/10.1002/cia2.12278 
787 0 |n https://doaj.org/toc/2574-4593 
856 4 1 |u https://doaj.org/article/883fc9ab78e04b82bd8ccbb99d9b7e66  |z Connect to this object online.